T. Rowe Price Investment Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-727,610
Closed -$12.4M 627
2023
Q3
$12.4M Hold
727,610
0.01% 513
2023
Q2
$16.9M Sell
727,610
-502,531
-41% -$9.82M 0.01% 491
2023
Q1
$21.7M Sell
1,230,141
-6,576
-0.5% -$156K 0.02% 464
2022
Q4
$33.6M Buy
1,236,717
+9,847
+0.8% +$205K 0.03% 406
2022
Q3
$21.2M Buy
+1,226,870
New +$23.4M 0.02% 445

Other funds holding REPL

T. Rowe Price Investment Management's REPL Position: Q4 2023 in Review

T. Rowe Price Investment Management sold out of Replimune Group (REPL) in Q4 2023, closing a stake of 727,610 shares — an estimated $12.4M sold.

T. Rowe Price Investment Management first reported a position in REPL in Q3 2022 and held it in 5 quarters. The position peaked at $33.6M in Q4 2022. 140 funds tracked by Wall St. Rank hold REPL as of Q4 2023.

  • T. Rowe Price Investment Management reported no remaining Replimune Group position as of Q4 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 727,610 Replimune Group shares in Q4 2023, an estimated $12.4M.
  • T. Rowe Price Investment Management first reported a position in Replimune Group in Q3 2022 and held it in 5 quarters.
  • T. Rowe Price Investment Management's Replimune Group position peaked at $33.6M in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q4 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.